Pazufloxacin

Pazufloxacin
Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	J01MA18 (WHO) ;
Identifiers
	IUPAC name (3R)-10-(1-aminocyclopropyl)-9-fluoro-3-methyl-7-oxo-1H,7H- [1,3]oxazino[5,4,3-ij]quinoline-carboxylic acid;
CAS Number	127045-41-4 ;
PubChem CID	65957;
ChemSpider	59360;
UNII	4CZ1R38NDI;
CompTox Dashboard (EPA)	DTXSID5046697 ;
ECHA InfoCard	100.162.962
Chemical and physical data
Formula	C16H15FN2O4
Molar mass	318.304 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C[C@H]1COC2=C3N1C=C(C(=O)C3=CC(=C2C4(CC4)N)F)C(=O)O;
	InChI InChI=1S/C16H15FN2O4/c1-7-6-23-14-11(16(18)2-3-16)10(17)4-8-12(14)19(7)5-9(13(8)20)15(21)22/h4-5,7H,2-3,6,18H2,1H3,(H,21,22)/t7-/m0/s1; Key:XAGMUUZPGZWTRP-ZETCQYMHSA-N;
	(verify)

Pazufloxacin (INN) is a fluoroquinolone antibiotic.^[1] It is sold in Japan under the brand names Pasil and Pazucross.

References

^ Rubinstein E (2001). "History of quinolones and their side effects". Chemotherapy. 47 Suppl 3 (3): 3–8, discussion 44-8. doi:10.1159/000057838. PMID 11549783. S2CID 21890070.